Sort   by:  
 Page size 
TranscriptomicsTranscription profiling of human CD34+CD38- and CD34+CD38+ cells from patients with acute myelogenous leukemia (AML)
Not available
ORGANISM(S): Homo sapiens 
2008-08-01 | E-NCMF-11 | biostudies-arrayexpress
UnknownMyeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.
Not available
S-EPMC4872304 | biostudies-literature
ProteomicsHuman AML secretome and exosomes and correlation with Anti-Apoptotic Index, part 3
Expression of proteins regulating apoptosis (BCL-2, MCL-1, BCL-X and BAX) in acute myeloid leukemia (AML) blasts at diagnosis have been shown to be associated with disease-free survival. We previously found that the initially high apoptosis-resistance of AML cells decreased after therapy, while rega...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2016-10-21 | MSV000080268 | MassIVE
ProteomicsHuman AML secretome and exosomes and correlation with Anti-Apoptotic Index, part 4
Expression of proteins regulating apoptosis (BCL-2, MCL-1, BCL-X and BAX) in acute myeloid leukemia (AML) blasts at diagnosis have been shown to be associated with disease-free survival. The concentrations of these proteins are combined in the Anti Apoptotic index (AAI). We previously found that th...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2016-10-21 | MSV000080266 | MassIVE
TranscriptomicsBortezomib resistance in CCRF-CEM cell line [CGH]
Bortezomib is a proteasome inhibitor used in severel different hematological malignancies. Resistance to this drug is still poorly understood. In order get more insight in the resistance mechanism, we developed several bortezomib resistant subclones of the CCRF-CEM T-ALL cell line. On these subclone...
ORGANISM(S): Homo sapiens 
2015-11-04 | E-GEOD-74633 | biostudies-arrayexpress
UnknownT-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.
Not available
S-EPMC12580724 | biostudies-literature
TranscriptomicsBortezomib resistance in CCRF-CEM cell line [GEP]
Bortezomib is a proteasome inhibitor used in severel different hematological malignancies. Resistance to this drug is still poorly understood. In order get more insight in the resistance mechanism, we developed several bortezomib resistant subclones of the CCRF-CEM T-ALL cell line. On these subclone...
ORGANISM(S): Homo sapiens 
2015-11-04 | E-GEOD-74634 | biostudies-arrayexpress
Sort   by:  
 Page size